2hr7 › Citations

The first three domains of the insulin receptor differ structurally from the insulin-like growth factor 1 receptor in the regions governing ligand specificity.

Lou M, Garrett TP, McKern NM, Hoyne PA, Epa VC, Bentley JD, Lovrecz GO, Cosgrove LJ, Frenkel MJ, Ward CW
Proc Natl Acad Sci U S A 103 12429-34 (2006)
Cited: 97 times
EuropePMC logo PMID: 16894147

Abstract

The insulin receptor (IR) and the type-1 insulin-like growth factor receptor (IGF1R) are homologous multidomain proteins that bind insulin and IGF with differing specificity. Here we report the crystal structure of the first three domains (L1-CR-L2) of human IR at 2.3 A resolution and compare it with the previously determined structure of the corresponding fragment of IGF1R. The most important differences seen between the two receptors are in the two regions governing ligand specificity. The first is at the corner of the ligand-binding surface of the L1 domain, where the side chain of F39 in IR forms part of the ligand binding surface involving the second (central) beta-sheet. This is very different to the location of its counterpart in IGF1R, S35, which is not involved in ligand binding. The second major difference is in the sixth module of the CR domain, where IR contains a larger loop that protrudes further into the ligand-binding pocket. This module, which governs IGF1-binding specificity, shows negligible sequence identity, significantly more alpha-helix, an additional disulfide bond, and opposite electrostatic potential compared to that of the IGF1R.

Reviews - 2hr7 mentioned but not cited (5)

  1. Understanding insulin and its receptor from their three-dimensional structures. Lawrence MC. Mol Metab 52 101255 (2021)
  2. Insulin and epidermal growth factor receptor family members share parallel activation mechanisms. Ferguson KM, Hu C, Lemmon MA. Protein Sci 29 1331-1344 (2020)
  3. Theoretical and computational studies of peptides and receptors of the insulin family. Vashisth H. Membranes (Basel) 5 48-83 (2015)
  4. The Insulin Receptor: An Important Target for the Development of Novel Medicines and Pesticides. Zhang X, Zhu X, Bi X, Huang J, Zhou L. Int J Mol Sci 23 7793 (2022)
  5. Aggregation propensity of neuronal receptors: potential implications in neurodegenerative disorders. Navarro S, Diaz-Caballero M, Illa R, Ventura S. Future Sci OA 1 FSO39 (2015)

Articles - 2hr7 mentioned but not cited (19)

  1. How insulin engages its primary binding site on the insulin receptor. Menting JG, Whittaker J, Margetts MB, Whittaker LJ, Kong GK, Smith BJ, Watson CJ, Záková L, Kletvíková E, Jiráček J, Chan SJ, Steiner DF, Dodson GG, Brzozowski AM, Weiss MA, Ward CW, Lawrence MC. Nature 493 241-245 (2013)
  2. The first three domains of the insulin receptor differ structurally from the insulin-like growth factor 1 receptor in the regions governing ligand specificity. Lou M, Garrett TP, McKern NM, Hoyne PA, Epa VC, Bentley JD, Lovrecz GO, Cosgrove LJ, Frenkel MJ, Ward CW. Proc Natl Acad Sci U S A 103 12429-12434 (2006)
  3. Higher-Resolution Structure of the Human Insulin Receptor Ectodomain: Multi-Modal Inclusion of the Insert Domain. Croll TI, Smith BJ, Margetts MB, Whittaker J, Weiss MA, Ward CW, Lawrence MC. Structure 24 469-476 (2016)
  4. A network pharmacology approach to understanding the mechanisms of action of traditional medicine: Bushenhuoxue formula for treatment of chronic kidney disease. Shi SH, Cai YP, Cai XJ, Zheng XY, Cao DS, Ye FQ, Xiang Z. PLoS One 9 e89123 (2014)
  5. A comparative structural bioinformatics analysis of the insulin receptor family ectodomain based on phylogenetic information. Rentería ME, Gandhi NS, Vinuesa P, Helmerhorst E, Mancera RL. PLoS One 3 e3667 (2008)
  6. Enhancing the activity of a protein by stereospecific unfolding: conformational life cycle of insulin and its evolutionary origins. Hua QX, Xu B, Huang K, Hu SQ, Nakagawa S, Jia W, Wang S, Whittaker J, Katsoyannis PG, Weiss MA. J Biol Chem 284 14586-14596 (2009)
  7. NMR-derived topology of a GFP-photoprotein energy transfer complex. Titushin MS, Feng Y, Stepanyuk GA, Li Y, Markova SV, Golz S, Wang BC, Lee J, Wang J, Vysotski ES, Liu ZJ. J Biol Chem 285 40891-40900 (2010)
  8. A structurally minimized yet fully active insulin based on cone-snail venom insulin principles. Xiong X, Menting JG, Disotuar MM, Smith NA, Delaine CA, Ghabash G, Agrawal R, Wang X, He X, Fisher SJ, MacRaild CA, Norton RS, Gajewiak J, Forbes BE, Smith BJ, Safavi-Hemami H, Olivera B, Lawrence MC, Chou DH. Nat Struct Mol Biol 27 615-624 (2020)
  9. Landmarks in insulin research. Ward CW, Lawrence MC. Front Endocrinol (Lausanne) 2 76 (2011)
  10. Insulin Mimetic Peptide Disrupts the Primary Binding Site of the Insulin Receptor. Lawrence CF, Margetts MB, Menting JG, Smith NA, Smith BJ, Ward CW, Lawrence MC. J Biol Chem 291 15473-15481 (2016)
  11. A Comprehensive Survey of the Roles of Highly Disordered Proteins in Type 2 Diabetes. Du Z, Uversky VN. Int J Mol Sci 18 E2010 (2017)
  12. In silico analysis of antidiabetic potential of phenolic compounds from blue corn (Zea mays L.) and black bean (Phaseolus vulgaris L.). Damián-Medina K, Salinas-Moreno Y, Milenkovic D, Figueroa-Yáñez L, Marino-Marmolejo E, Higuera-Ciapara I, Vallejo-Cardona A, Lugo-Cervantes E. Heliyon 6 e03632 (2020)
  13. Galangin and Pinocembrin from Propolis Ameliorate Insulin Resistance in HepG2 Cells via Regulating Akt/mTOR Signaling. Liu Y, Liang X, Zhang G, Kong L, Peng W, Zhang H. Evid Based Complement Alternat Med 2018 7971842 (2018)
  14. Founder effect in the Horn of Africa for an insulin receptor mutation that may impair receptor recycling. Raffan E, Soos MA, Rocha N, Tuthill A, Thomsen AR, Hyden CS, Gregory JW, Hindmarsh P, Dattani M, Cochran E, Al Kaabi J, Gorden P, Barroso I, Morling N, O'Rahilly S, Semple RK. Diabetologia 54 1057-1065 (2011)
  15. Computational Analysis of Damaging Single-Nucleotide Polymorphisms and Their Structural and Functional Impact on the Insulin Receptor. Mahmud Z, Malik SU, Ahmed J, Azad AK. Biomed Res Int 2016 2023803 (2016)
  16. The dipeptidyl peptidase IV inhibitors vildagliptin and K-579 inhibit a phospholipase C: a case of promiscuous scaffolds in proteins. Chakraborty S, Rendón-Ramírez A, Ásgeirsson B, Dutta M, Ghosh AS, Oda M, Venkatramani R, Rao BJ, Dandekar AM, Goñi FM. F1000Res 2 286 (2013)
  17. A docking study of insulin with LI-CR-L2 ecto domain of insulin receptor: an easy way for preliminary screening of novel anti-diabetic peptides. Bhattacharyya R, Banerjee D. Bioinformation 8 1082-1086 (2012)
  18. Antihypertensive effect and mechanism of the traditional recipe of medicine food homology (Buyang Huanwu Decoction) in China: Meta analysis and network pharmacological exploration. Li B, Lu C, Liu Y, Wang X, Fu H, Li C, Sun M, Zhang Y, Li M. Heliyon 10 e23474 (2024)
  19. Cellular mechanism of action of forsythiaside for the treatment of diabetic kidney disease. Xu C, Miao H, Chen X, Zhang H. Front Pharmacol 13 1096536 (2022)


Reviews citing this publication (17)

  1. Insulin receptor isoforms and insulin receptor/insulin-like growth factor receptor hybrids in physiology and disease. Belfiore A, Frasca F, Pandini G, Sciacca L, Vigneri R. Endocr Rev 30 586-623 (2009)
  2. Insulin Receptor Isoforms in Physiology and Disease: An Updated View. Belfiore A, Malaguarnera R, Vella V, Lawrence MC, Sciacca L, Frasca F, Morrione A, Vigneri R. Endocr Rev 38 379-431 (2017)
  3. Mechanisms of disease: signaling of the insulin-like growth factor 1 receptor pathway--therapeutic perspectives in cancer. Tao Y, Pinzi V, Bourhis J, Deutsch E. Nat Clin Pract Oncol 4 591-602 (2007)
  4. The insulin receptor: a prototype for dimeric, allosteric membrane receptors? De Meyts P. Trends Biochem Sci 33 376-384 (2008)
  5. Insulin receptor structure and its implications for the IGF-1 receptor. Lawrence MC, McKern NM, Ward CW. Curr Opin Struct Biol 17 699-705 (2007)
  6. Ligand-induced activation of the insulin receptor: a multi-step process involving structural changes in both the ligand and the receptor. Ward CW, Lawrence MC. Bioessays 31 422-434 (2009)
  7. The insulin and EGF receptor structures: new insights into ligand-induced receptor activation. Ward CW, Lawrence MC, Streltsov VA, Adams TE, McKern NM. Trends Biochem Sci 32 129-137 (2007)
  8. The insulin receptor changes conformation in unforeseen ways on ligand binding: sharpening the picture of insulin receptor activation. Ward CW, Menting JG, Lawrence MC. Bioessays 35 945-54, doi/10.1002/bies.201370111 (2013)
  9. Pharmacologic therapy that simulates conditioning for cardiac ischemic/reperfusion injury. Sivaraman V, Yellon DM. J Cardiovasc Pharmacol Ther 19 83-96 (2014)
  10. Reactivation of the insulin-like growth factor-II signaling pathway in human hepatocellular carcinoma. Breuhahn K, Schirmacher P. World J Gastroenterol 14 1690-1698 (2008)
  11. Insulin: a small protein with a long journey. Hua Q. Protein Cell 1 537-551 (2010)
  12. Structural insights into ligand-induced activation of the insulin receptor. Ward C, Lawrence M, Streltsov V, Garrett T, McKern N, Lou MZ, Lovrecz G, Adams T. Acta Physiol (Oxf) 192 3-9 (2008)
  13. Understanding IGF-II Action through Insights into Receptor Binding and Activation. Blyth AJ, Kirk NS, Forbes BE. Cells 9 E2276 (2020)
  14. Insulin receptor-related receptor as an extracellular pH sensor involved in the regulation of acid-base balance. Petrenko AG, Zozulya SA, Deyev IE, Eladari D. Biochim Biophys Acta 1834 2170-2175 (2013)
  15. Disrupting Insulin and IGF Receptor Function in Cancer. Cao J, Yee D. Int J Mol Sci 22 E555 (2021)
  16. Vale Neil McKern - Australian Insulin Receptor Scientist. Ward CW, Lawrence MC. Front Endocrinol (Lausanne) 5 105 (2014)
  17. Insulin Receptor Isoforms and Insulin Growth Factor-like Receptors: Implications in Cell Signaling, Carcinogenesis, and Chemoresistance. Galal MA, Alouch SS, Alsultan BS, Dahman H, Alyabis NA, Alammar SA, Aljada A. Int J Mol Sci 24 15006 (2023)

Articles citing this publication (56)

  1. Structure of the insulin receptor ectodomain reveals a folded-over conformation. McKern NM, Lawrence MC, Streltsov VA, Lou MZ, Adams TE, Lovrecz GO, Elleman TC, Richards KM, Bentley JD, Pilling PA, Hoyne PA, Cartledge KA, Pham TM, Lewis JL, Sankovich SE, Stoichevska V, Da Silva E, Robinson CP, Frenkel MJ, Sparrow LG, Fernley RT, Epa VC, Ward CW. Nature 443 218-221 (2006)
  2. Characterization of insulin/IGF hybrid receptors: contributions of the insulin receptor L2 and Fn1 domains and the alternatively spliced exon 11 sequence to ligand binding and receptor activation. Benyoucef S, Surinya KH, Hadaschik D, Siddle K. Biochem J 403 603-613 (2007)
  3. Harmonic oscillator model of the insulin and IGF1 receptors' allosteric binding and activation. Kiselyov VV, Versteyhe S, Gauguin L, De Meyts P. Mol Syst Biol 5 243 (2009)
  4. Structural resolution of a tandem hormone-binding element in the insulin receptor and its implications for design of peptide agonists. Smith BJ, Huang K, Kong G, Chan SJ, Nakagawa S, Menting JG, Hu SQ, Whittaker J, Steiner DF, Katsoyannis PG, Ward CW, Weiss MA, Lawrence MC. Proc Natl Acad Sci U S A 107 6771-6776 (2010)
  5. Ligand-induced structural transitions in ErbB receptor extracellular domains. Dawson JP, Bu Z, Lemmon MA. Structure 15 942-954 (2007)
  6. How ligand binds to the type 1 insulin-like growth factor receptor. Xu Y, Kong GK, Menting JG, Margetts MB, Delaine CA, Jenkin LM, Kiselyov VV, De Meyts P, Forbes BE, Lawrence MC. Nat Commun 9 821 (2018)
  7. Diversification of the insulin receptor family in the helminth parasite Schistosoma mansoni. Khayath N, Vicogne J, Ahier A, BenYounes A, Konrad C, Trolet J, Viscogliosi E, Brehm K, Dissous C. FEBS J 274 659-676 (2007)
  8. The direct binding of insulin-like growth factor-1 (IGF-1) to integrin alphavbeta3 is involved in IGF-1 signaling. Saegusa J, Yamaji S, Ieguchi K, Wu CY, Lam KS, Liu FT, Takada YK, Takada Y. J Biol Chem 284 24106-24114 (2009)
  9. Insulin/receptor binding: the last piece of the puzzle? What recent progress on the structure of the insulin/receptor complex tells us (or not) about negative cooperativity and activation. De Meyts P. Bioessays 37 389-397 (2015)
  10. Cloning and characterisation of Schistosoma japonicum insulin receptors. You H, Zhang W, Jones MK, Gobert GN, Mulvenna J, Rees G, Spanevello M, Blair D, Duke M, Brehm K, McManus DP. PLoS One 5 e9868 (2010)
  11. N-linked glycans of the human insulin receptor and their distribution over the crystal structure. Sparrow LG, Lawrence MC, Gorman JJ, Strike PM, Robinson CP, McKern NM, Ward CW. Proteins 71 426-439 (2008)
  12. Insulin receptor-related receptor as an extracellular alkali sensor. Deyev IE, Sohet F, Vassilenko KP, Serova OV, Popova NV, Zozulya SA, Burova EB, Houillier P, Rzhevsky DI, Berchatova AA, Murashev AN, Chugunov AO, Efremov RG, Nikol'sky NN, Bertelli E, Eladari D, Petrenko AG. Cell Metab 13 679-689 (2011)
  13. Alanine scanning of a putative receptor binding surface of insulin-like growth factor-I. Gauguin L, Delaine C, Alvino CL, McNeil KA, Wallace JC, Forbes BE, De Meyts P. J Biol Chem 283 20821-20829 (2008)
  14. Role of receptor tyrosine kinases and their ligands in glioblastoma. Carrasco-García E, Saceda M, Martínez-Lacaci I. Cells 3 199-235 (2014)
  15. Evolutionary genetics and implications of small size and twinning in callitrichine primates. Harris RA, Tardif SD, Vinar T, Wildman DE, Rutherford JN, Rogers J, Worley KC, Aagaard KM. Proc Natl Acad Sci U S A 111 1467-1472 (2014)
  16. Structural Congruency of Ligand Binding to the Insulin and Insulin/Type 1 Insulin-like Growth Factor Hybrid Receptors. Menting JG, Lawrence CF, Kong GK, Margetts MB, Ward CW, Lawrence MC. Structure 23 1271-1282 (2015)
  17. The location and characterisation of the O-linked glycans of the human insulin receptor. Sparrow LG, Gorman JJ, Strike PM, Robinson CP, McKern NM, Epa VC, Ward CW. Proteins 66 261-265 (2007)
  18. Solution structure of ectodomains of the insulin receptor family: the ectodomain of the type 1 insulin-like growth factor receptor displays asymmetry of ligand binding accompanied by limited conformational change. Whitten AE, Smith BJ, Menting JG, Margetts MB, McKern NM, Lovrecz GO, Adams TE, Richards K, Bentley JD, Trewhella J, Ward CW, Lawrence MC. J Mol Biol 394 878-892 (2009)
  19. The structure and function of insulin: decoding the TR transition. Weiss MA. Vitam Horm 80 33-49 (2009)
  20. A twenty-first century cancer epidemic caused by obesity: the involvement of insulin, diabetes, and insulin-like growth factors. Westley RL, May FE. Int J Endocrinol 2013 632461 (2013)
  21. Contribution of TyrB26 to the Function and Stability of Insulin: STRUCTURE-ACTIVITY RELATIONSHIPS AT A CONSERVED HORMONE-RECEPTOR INTERFACE. Pandyarajan V, Phillips NB, Rege N, Lawrence MC, Whittaker J, Weiss MA. J Biol Chem 291 12978-12990 (2016)
  22. All-atom structural models of insulin binding to the insulin receptor in the presence of a tandem hormone-binding element. Vashisth H, Abrams CF. Proteins 81 1017-1030 (2013)
  23. Aromatic anchor at an invariant hormone-receptor interface: function of insulin residue B24 with application to protein design. Pandyarajan V, Smith BJ, Phillips NB, Whittaker L, Cox GP, Wickramasinghe N, Menting JG, Wan ZL, Whittaker J, Ismail-Beigi F, Lawrence MC, Weiss MA. J Biol Chem 289 34709-34727 (2014)
  24. Targeting Insulin Receptor in Breast Cancer Using Small Engineered Protein Scaffolds. Chan JY, Hackel BJ, Yee D. Mol Cancer Ther 16 1324-1334 (2017)
  25. α-Helical element at the hormone-binding surface of the insulin receptor functions as a signaling element to activate its tyrosine kinase. Whittaker J, Whittaker LJ, Roberts CT, Phillips NB, Ismail-Beigi F, Lawrence MC, Weiss MA. Proc Natl Acad Sci U S A 109 11166-11171 (2012)
  26. Exploring the implications of vitamin B12 conjugation to insulin on insulin receptor binding. Petrus AK, Allis DG, Smith RP, Fairchild TJ, Doyle RP. ChemMedChem 4 421-426 (2009)
  27. Docking of insulin to a structurally equilibrated insulin receptor ectodomain. Vashisth H, Abrams CF. Proteins 78 1531-1543 (2010)
  28. Novel missense mutation in the IGF-I receptor L2 domain results in intrauterine and postnatal growth retardation. Kawashima Y, Higaki K, Fukushima T, Hakuno F, Nagaishi J, Hanaki K, Nanba E, Takahashi S, Kanzaki S. Clin Endocrinol (Oxf) 77 246-254 (2012)
  29. Systematic evaluation of the metabolic to mitogenic potency ratio for B10-substituted insulin analogues. Glendorf T, Knudsen L, Stidsen CE, Hansen BF, Hegelund AC, Sørensen AR, Nishimura E, Kjeldsen T. PLoS One 7 e29198 (2012)
  30. Dimerization and negative cooperativity in the relaxin family peptide receptors. Svendsen AM, Vrecl M, Knudsen L, Heding A, Wade JD, Bathgate RA, De Meyts P, Nøhr J. Ann N Y Acad Sci 1160 54-59 (2009)
  31. RILM: a web-based resource to aid comparative and functional analysis of the insulin and IGF-1 receptor family. Garza-Garcia A, Patel DS, Gems D, Driscoll PC. Hum Mutat 28 660-668 (2007)
  32. Solution structure of an ultra-stable single-chain insulin analog connects protein dynamics to a novel mechanism of receptor binding. Glidden MD, Yang Y, Smith NA, Phillips NB, Carr K, Wickramasinghe NP, Ismail-Beigi F, Lawrence MC, Smith BJ, Weiss MA. J Biol Chem 293 69-88 (2018)
  33. Structural Perspectives of Insulin Receptor Isoform-Selective Insulin Analogs. Jiráček J, Žáková L. Front Endocrinol (Lausanne) 8 167 (2017)
  34. Symmetric and asymmetric receptor conformation continuum induced by a new insulin. Xiong X, Blakely A, Kim JH, Menting JG, Schäfer IB, Schubert HL, Agrawal R, Gutmann T, Delaine C, Zhang YW, Artik GO, Merriman A, Eckert D, Lawrence MC, Coskun Ü, Fisher SJ, Forbes BE, Safavi-Hemami H, Hill CP, Chou DH. Nat Chem Biol 18 511-519 (2022)
  35. Flexibility in the insulin receptor ectodomain enables docking of insulin in crystallographic conformation observed in a hormone-bound microreceptor. Vashisth H. Membranes (Basel) 4 730-746 (2014)
  36. Functional collaboration of insulin-like growth factor-1 receptor (IGF-1R), but not insulin receptor (IR), with acute GH signaling in mouse calvarial cells. Gan Y, Paterson AJ, Zhang Y, Jiang J, Frank SJ. Endocrinology 155 1000-1009 (2014)
  37. Design of an insulin analog with enhanced receptor binding selectivity: rationale, structure, and therapeutic implications. Zhao M, Wan ZL, Whittaker L, Xu B, Phillips NB, Katsoyannis PG, Ismail-Beigi F, Whittaker J, Weiss MA. J Biol Chem 284 32178-32187 (2009)
  38. Improving expression of recombinant human IGF-1 using IGF-1R knockout CHO cell lines. Romand S, Jostock T, Fornaro M, Schmidt J, Ritter A, Wilms B, Laux H. Biotechnol Bioeng 113 1094-1101 (2016)
  39. Insulin mimetic peptide S371 folds into a helical structure. Mohammadiarani H, Vashisth H. J Comput Chem 38 1158-1166 (2017)
  40. A viral insulin-like peptide is a natural competitive antagonist of the human IGF-1 receptor. Zhang F, Altindis E, Kahn CR, DiMarchi RD, Gelfanov V. Mol Metab 53 101316 (2021)
  41. All-Atom Structural Models of the Transmembrane Domains of Insulin and Type 1 Insulin-Like Growth Factor Receptors. Mohammadiarani H, Vashisth H. Front Endocrinol (Lausanne) 7 68 (2016)
  42. Molecular characterization of a novel p.R118C mutation in the insulin receptor gene from patients with severe insulin resistance. Alzahrani AS, Zou M, Baitei EY, Parhar RS, Al-Kahtani N, Raef H, Almahfouz A, Amartey JK, Al-Rijjal R, Hammami R, Meyer BF, Al-Mohanna FA, Shi Y. Clin Endocrinol (Oxf) 76 540-547 (2012)
  43. Activation of the insulin receptor by an insulin mimetic peptide. Park J, Li J, Mayer JP, Ball KA, Wu J, Hall C, Accili D, Stowell MHB, Bai XC, Choi E. Nat Commun 13 5594 (2022)
  44. Structural interpretation of reduced insulin activity as seen in the crystal structure of human Arg-insulin. Sreekanth R, Pattabhi V, Rajan SS. Biochimie 90 467-473 (2008)
  45. A versatile insulin analog with high potency for both insulin and insulin-like growth factor 1 receptors: Structural implications for receptor binding. Chrudinová M, Žáková L, Marek A, Socha O, Buděšínský M, Hubálek M, Pícha J, Macháčková K, Jiráček J, Selicharová I. J Biol Chem 293 16818-16829 (2018)
  46. Affinity modulation of human placental insulin and insulin-like growth factor receptors by lectins. Masnikosa R, Nikolić A, Nedić O. J Biochem 143 813-820 (2008)
  47. Coevolution of insulin-like growth factors, insulin and their receptors and binding proteins in New World Monkeys. Wallis M. Growth Horm IGF Res 25 158-167 (2015)
  48. Fluorescent IGF-II analogues for FRET-based investigations into the binding of IGF-II to the IGF-1R. Cottam Jones JM, Harris PW, Scanlon DB, Forbes BE, Brimble MA, Abell AD. Org Biomol Chem 14 2698-2705 (2016)
  49. How insulin-like growth factor I binds to a hybrid insulin receptor type 1 insulin-like growth factor receptor. Xu Y, Margetts MB, Venugopal H, Menting JG, Kirk NS, Croll TI, Delaine C, Forbes BE, Lawrence MC. Structure 30 1098-1108.e6 (2022)
  50. Letter Insulin and its receptor: a grand challenge in structural biology. Lawrence MC. Biophys Rev 543-545 (2019)
  51. Polymorphism in exon 2 encoding the putative ligand binding pocket of the bovine insulin-like growth factor 1 receptor affects milk traits in four different cattle breeds. Szewczuk M. J Anim Breed Genet 134 34-42 (2017)
  52. Structural basis for the poisonous activity of a predator's venom insulin. De Meyts P. Nat Struct Mol Biol 23 872-874 (2016)
  53. Single-chain insulin analogs threaded by the insulin receptor αCT domain. Smith NA, Menting JG, Weiss MA, Lawrence MC, Smith BJ. Biophys J 121 4063-4077 (2022)
  54. Structural models of viral insulin-like peptides and their analogs. Gorai B, Vashisth H. Proteins 91 62-73 (2023)
  55. Synthesis, antitumor evaluation and computational study of thiazolidinone derivatives of dehydroabietic acid-based B ring-fused-thiazole. Chen NY, Li CP, Huang HF. Mol Divers (2023)
  56. Vale Colin Ward-A Leader in Receptor Structural Biology. Lawrence MC, Colman PM. Front Endocrinol (Lausanne) 8 95 (2017)


Quick links